Jordana Fein
Retina Specialist · Manassas, VANPI 1841463098
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $267,314 of the $411,601 with a category attached, or 64.9%. 23 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 51.6% of the total. Among retina specialist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 434 payments — averaging $948.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$212K
- Apellis Pharmaceuticals, Inc.$119K
- Genentech USA, Inc.$52K
- Regeneron$11K
- Harrow Eye, LLC$6K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$4K
- plus $7K from 17 others
Across 618 payments — averaging $2439.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Apellis Pharmaceuticals, Inc.$431K
- Bayer$377K
- Regeneron$315K
- AstraZeneca$219K
- Ocular Therapeutix, Inc.$111K
- Kyowa Kirin, Inc.$55K
- plus $840 from 1 others
What the payments were for
- Consulting fees$107,25226%
- Speaking & faculty fees$267,31465%
- Travel & lodging$25,9576%
- Food & beverage$11,0783%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 174 | $212,237 |
| Apellis Pharmaceuticals, Inc. | 101 | $119,493 |
| Genentech USA, Inc. | 54 | $52,432 |
| Regeneron | 18 | $10,621 |
| Harrow Eye, LLC | 5 | $5,669 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $3,858 |
| Bausch & Lomb Americas Inc. | 16 | $3,751 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| AbbVie(2 entities) | 25 | $638 |
| Novartis | 8 | $324 |
| Astellas Pharma US Inc | 5 | $168 |
| Biotissue Holdings Inc. | 1 | $137 |
| Ocular Therapeutix, Inc. | 3 | $133 |
| Dompe US, Inc. | 1 | $125 |
| Eyepoint US, Inc. | 6 | $123 |
| Alcon | 1 | $115 |
| Alimera Sciences, Inc. | 2 | $51 |
| Neurotech Pharmaceuticals, Inc. | 1 | $43 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Astellas Pharma Global Development | 1 | $23 |
| Notal Vision, Inc. | 1 | $19 |
| Vyera Pharmaceuticals, LLC | 1 | $17 |
| Genentech, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$411,601 in reported general payments places this provider in the 95th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 52 | $2,126 |
| Ofloxacin | 28 | $376 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $217 |
| Latanoprost | 21 | $174 |
| Timolol Maleate | 18 | $49 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Manassas
- Andy HayManassas$19
- Joaquin TosiVirginia Beach$48K
- Mohit NandaCharlottesville$31K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
- Jiwei ShengFairfax$8K
- Timothy ByrnesRoanoke$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.